Invesco Ltd. - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 158 filers reported holding CLOVIS ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2022$101,000
-24.6%
49,947
+1.4%
0.00%
Q4 2021$134,000
-41.0%
49,243
-3.1%
0.00%
Q3 2021$227,000
-2.2%
50,815
+26.8%
0.00%
Q2 2021$232,000
+58.9%
40,072
+92.5%
0.00%
Q1 2021$146,000
+82.5%
20,818
+24.6%
0.00%
Q4 2020$80,000
-93.5%
16,704
-85.8%
0.00%
Q4 2019$1,228,000
+1981.4%
117,780
+690.4%
0.00%
Q3 2019$59,000
-74.3%
14,902
-3.6%
0.00%
Q2 2019$230,000
-42.1%
15,460
-3.3%
0.00%
Q1 2019$397,000
-95.9%
15,991
-95.1%
0.00%
-100.0%
Q3 2018$9,578,000
-38.6%
326,122
-4.9%
0.00%
-40.0%
Q2 2018$15,600,000
-14.9%
343,101
-1.1%
0.01%
-28.6%
Q1 2018$18,326,000
-23.9%
347,086
-2.0%
0.01%
-22.2%
Q4 2017$24,075,000
-39.2%
354,045
-26.3%
0.01%
-40.0%
Q3 2017$39,599,000
+2.9%
480,582
+16.9%
0.02%
+25.0%
Q2 2017$38,484,000
+41.4%
411,024
-3.9%
0.01%
+33.3%
Q1 2017$27,222,000
+436.2%
427,564
+274.1%
0.01%
+350.0%
Q4 2016$5,077,000
+1169.2%
114,298
+929.2%
0.00%
Q3 2016$400,000
-86.8%
11,105
-87.1%
0.00%
-100.0%
Q4 2015$3,024,000
-82.5%
86,399
-53.9%
0.00%
-85.7%
Q3 2015$17,236,000
+37.9%
187,422
+31.7%
0.01%
+40.0%
Q2 2015$12,502,000
+57.8%
142,258
+33.3%
0.01%
+66.7%
Q1 2015$7,922,000
-16.1%
106,720
-36.7%
0.00%
-25.0%
Q4 2014$9,443,000
+36.3%
168,631
+10.4%
0.00%
+33.3%
Q3 2014$6,929,000
+17.2%
152,753
+7.0%
0.00%
+50.0%
Q2 2014$5,913,000
-45.5%
142,789
-8.9%
0.00%
-50.0%
Q1 2014$10,859,000
+335.9%
156,760
+279.3%
0.00%
+300.0%
Q4 2013$2,491,000
+271.2%
41,330
+312.4%
0.00%
Q2 2013$671,00010,0210.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders